News & Events

What’s happening at InnoCore?

Discover what InnoCore has been doing with its world-class technology, SynBiosys®.

16 September 2025 | Latest News
InnoCore Pharmaceuticals Signs Project Extension for Long-Acting Injectable Formulation of a Protein Candidate
InnoCore Pharmaceuticals today announced a project extension with an existing European biotech partner focused on developing a long-acting injectable protein formulation using its proprietary SynBiosys® technology.
Read the full story
11 September 2025 | Latest News
InnoCore Pharmaceuticals Signs New Long-Acting Injectable Formulation Contract with Returning Top 10 Global Pharma Partner
InnoCore Pharmaceuticals today announced a new formulation development contract with a returning Top 10 global pharmaceutical company. The new agreement builds on the success of earlier collaborations and further strengthens the long-standing relationship between the two companies.
Read the full story
Vienna, 3 - 5 November 2025
BioEurope – Vienna
Meet us at the BioEurope in Vienna from 3 - 5 November! Let’s build the future of Biologics and Peptides together.
Read the full story
CPHI - Frankfurt
Frankfurt, 29 & 30 October
CPHI – Frankfurt
Meet us at the CPHI to explore how our SynBiosys® platform is transforming the development of biodegradable long-acting injectables for peptides, proteins, and other biologics.
Read the full story
Boston, 27 & 28 October 2025
Partnerships in drug delivery – Boston
Join Rob Steendam, at his talk on “SynBiosys®: Long-Acting Injectable Microspheres and In Situ Forming Depots for Delivery of Peptides and Proteins”!
Read the full story
Yokohama, 8 - 10 October 2025
BioJapan - Yokohama
Join InnoCore at BioJapan! Let's partner to shape the future of peptides and biologics together.
Read the full story
InnoCore website launch
05 September 2025 | Latest News
New Website Launch!
InnoCore launches its new website
Read the full story
Boston, 15 - 16 September 2025
Drug Delivery & Formulation Summit – Boston
Our expert Aiva Simaite is eager to present at the DDF Summit in Boston!
Read the full story
15 July 2025 | Latest News
InnoCore Pharmaceuticals Announces New Collaboration with U.S. Biotech Partner Focused on Metabolic Disease
InnoCore Pharmaceuticals today announced a new partnership with a U.S.-based biotechnology company developing next-generation GLP-1 therapies for obesity and metabolic diseases.
Read the full story

To hear the latest news from InnoCore Pharmaceuticals, you can subscribe at any time.

Sign-up here